D.J. St. Germain’s Jazz Pharmaceuticals JAZZ Stock Holding History

D.J. St. Germain’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$61.3K	Hold	324	–	–	﹤0.01%	429
2025 Q4	$55.1K	Hold	324	–	–	﹤0.01%	465
2025 Q3	$42.7K	Hold	324	–	–	﹤0.01%	483
2025 Q2	$34.4K	Hold	324	–	–	﹤0.01%	510
2025 Q1	$40.2K	Hold	324	–	–	﹤0.01%	421
2024 Q4	$39.9K	Hold	324	–	–	﹤0.01%	442
2024 Q3	$36.1K	Hold	324	–	–	﹤0.01%	414
2024 Q2	$34.6K	Hold	324	–	–	﹤0.01%	411
2024 Q1	$39K	Hold	324	–	–	﹤0.01%	416
2023 Q4	$39.9K	Hold	324	–	–	﹤0.01%	420
2023 Q3	$41.9K	Hold	324	–	–	﹤0.01%	381
2023 Q2	$40.2K	Buy	+324	New	+$43.6K	﹤0.01%	396

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

D.J. St. Germain's JAZZ Position: Q1 2026 in Review

D.J. St. Germain held its Jazz Pharmaceuticals (JAZZ) position steady in Q1 2026 at 324 shares worth $61.3K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

D.J. St. Germain first reported a position in JAZZ in Q2 2023 and has held it in 12 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

D.J. St. Germain held 324 shares of Jazz Pharmaceuticals worth $61.3K as of Q1 2026.
D.J. St. Germain left its Jazz Pharmaceuticals share count unchanged in Q1 2026.
Jazz Pharmaceuticals made up ﹤0.01% of D.J. St. Germain's portfolio in Q1 2026, its #429 holding.
D.J. St. Germain first reported a position in Jazz Pharmaceuticals in Q2 2023 and has held it in 12 quarters since.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on D.J. St. Germain's 13F filing for Q1 2026, filed 13 Apr 2026.